Type 1 diabetes is a chronic autoimmune disease where the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. This results in the body being unable to produce enough insulin to regulate blood sugar levels effectively. As a result, individuals with type 1 diabetes must regularly monitor their blood sugar levels and administer insulin injections to maintain proper blood sugar control. Research in type 1 diabetes focuses on understanding the underlying causes of the disease, developing new treatments and therapies to improve blood sugar management, and ultimately finding a cure. This includes investigating genetic and environmental factors that may contribute to the development of type 1 diabetes, exploring novel ways to restore beta cell function, and developing new technologies for monitoring blood sugar levels and delivering insulin. Overall, research in type 1 diabetes is essential for improving the quality of life for individuals living with the disease and ultimately finding a cure to eliminate the need for daily insulin injections and blood sugar monitoring.